Endologix AFX2 Graft Risk Information Updated in FDA-Approved Labeling
The FDA is requiring new label warnings and post-marketing studies on the Endologix AFX2 graft system, which has been linked to potentially life-threatening endoleaks.
The FDA is requiring new label warnings and post-marketing studies on the Endologix AFX2 graft system, which has been linked to potentially life-threatening endoleaks.
A new study finds that women suffer worse outcomes and survival rates than men following aortic aneurysm repair surgery.
Following the advice of a panel of scientific advisors, the FDA is now calling on health care professionals to conduct lifelong surveillance of patients who have undergone abdominal aortic aneurysm…
The FDA is warning of potentially deadly endoleaks linked to endovascular graft systems, and call for patients with such systems to be closely monitored.
The FDA has announced a Medtronic stent graft system recall after reports of malfunctions, serious injuries, and at least one death.
A new study shows patients who address aortic aneurysms through elective surgery have a greater chance of survival than those who have to undergo aortic repair surgery due to an…
A new study adds to concerns antibiotics like Avelox, Cipro and Levaquin can cause aortic aneurysms which put patients' lives at risk.
The FDA warns patients who received Endologix AFX Endovascular graft systems follow up with their doctor annually due to the risk of endoleaks which could cause health complications.
A new study questions whether there is need for concern about aortic dissection and aortic aneurysm risks linked to Levaquin, Cipro and Avelox.
The FDA warns that a recalled stent graph could leak polymer into patients' bodies, posing a risk of severe injury and death.